An email exchange and an unusual meeting suggest a connection between an institute’s pursuit of industry support and the rejection of a grant application.
An analysis of President Trump’s proposed $7.2 billion slash to the National Institutes of Health budget points to dire consequences for the development of novel drugs.
The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.
A review of a 2014 incident in which mystery vials of smallpox were found at the NIH reveals security weaknesses, but also concludes the response was appropriate.
The number of young investigators with NIH grants has declined since 1982, but recent efforts by the agency to increase funding for early-stage investigators are working, a study finds.